Skip to content

Clinical trials

Colonic Neoplasms trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Colonic Neoplasms Country / region: Japan Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20062
20071
20085
20093
20111
20132
20172
20181
20191
20204
20221
20233
20242
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Recruiting9
Active, not recruiting7
Terminated3
Unknown status3
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company6
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan5
GlaxoSmithKline4
Pfizer4
City of Hope Medical Center3
Tokyo University2
Agendia1
Hamamatsu University1
Hutchison Medipharma Limited1
Incyte Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Colonic Neoplasms36
Colorectal Neoplasms21
Rectal Neoplasms13
Carcinoma, Non-Small-Cell Lung6
Neoplasms6
Lung Neoplasms5
Breast Neoplasms4
Head and Neck Neoplasms4
Intestinal Neoplasms4
Neoplasms by Site4

Trials

Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.